479 related articles for article (PubMed ID: 32448132)
21. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis E virus infection in Hong Kong blood donors.
Tsoi WC; Zhu X; To AP; Holmberg J
Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China.
Li M; Bu Q; Gong W; Li H; Wang L; Li S; Sridhar S; Cy Woo P; Wang L
J Matern Fetal Neonatal Med; 2020 Nov; 33(21):3647-3651. PubMed ID: 30760069
[No Abstract] [Full Text] [Related]
28. [Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia].
Hannachi N; Hidar S; Harrabi I; Mhalla S; Marzouk M; Ghzel H; Ghannem H; Khairi H; Boukadida J
Pathol Biol (Paris); 2011 Oct; 59(5):e115-8. PubMed ID: 19896306
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of Hepatitis E Virus infection among pregnant women in France.
Renou C; Gobert V; Locher C; Moumen A; Timbely O; Savary J; Roque-Afonso AM;
Virol J; 2014 Apr; 11():68. PubMed ID: 24716485
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hepatitis E virus in children from Northeast of Argentina.
Martínez AP; Pereson MJ; Pérez PS; Baeck MI; Mandó P; López Saubidet I; Di Lello FA
J Med Virol; 2021 Jun; 93(6):4015-4017. PubMed ID: 32639583
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.
Unzueta A; Valdez R; Chang YH; Desmarteau YM; Heilman RL; Scott RL; Douglas DD; Rakela J
Ann Hepatol; 2016; 15(1):33-40. PubMed ID: 26626638
[TBL] [Abstract][Full Text] [Related]
32. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC
J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.
Jilani N; Das BC; Husain SA; Baweja UK; Chattopadhya D; Gupta RK; Sardana S; Kar P
J Gastroenterol Hepatol; 2007 May; 22(5):676-82. PubMed ID: 17444855
[TBL] [Abstract][Full Text] [Related]
34. Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection.
Pisanic N; Rahman A; Saha SK; Labrique AB; Nelson KE; Granger DA; Granger SW; Detrick B; Heaney CD
J Immunol Methods; 2017 Sep; 448():1-8. PubMed ID: 28478117
[TBL] [Abstract][Full Text] [Related]
35. First detection of hepatitis E virus in Central Argentina: environmental and serological survey.
Martínez Wassaf MG; Pisano MB; Barril PA; Elbarcha OC; Pinto MA; Mendes de Oliveira J; DiGiusto P; Nates SV; Ré VE
J Clin Virol; 2014 Nov; 61(3):334-9. PubMed ID: 25213209
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon.
Feldt T; Sarfo FS; Zoufaly A; Phillips RO; Burchard G; van Lunzen J; Jochum J; Chadwick D; Awasom C; Claussen L; Drosten C; Drexler JF; Eis-Hübinger AM
J Clin Virol; 2013 Sep; 58(1):18-23. PubMed ID: 23743346
[TBL] [Abstract][Full Text] [Related]
37. High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India.
Pischke S; Schulze-Zur-Wiesch J; Lütgehetmann M; Kreuels B; Lueth S; Kapaun P; Benten D; Schmiedel S; Sterneck M; Lohse AW; Polywka S
Ann Hepatol; 2017; 16(1):57-62. PubMed ID: 28051793
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis E virus in blood donors from Argentina: A possible source of viral infection?
Pisano MB; Blanco S; Di Cola G; Fantilli AC; Martínez Wassaf MG; Carrizo LH; Ré VE; Gallego SV
Travel Med Infect Dis; 2022; 48():102355. PubMed ID: 35561878
[TBL] [Abstract][Full Text] [Related]
39. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical correlation of hepatitis E virus antibody in the patients' serum samples from a tertiary care hospital in Thailand during 2015-2018.
Boonyai A; Thongput A; Sisaeng T; Phumchan P; Horthongkham N; Kantakamalakul W; Chaimayo C
Virol J; 2021 Jul; 18(1):145. PubMed ID: 34247642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
